Clinical Trial Update: A Study of VET3-TGI in Patients With Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for VET3-TGI in patients with solid tumors, currently recruiting across multiple cancer types.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Colorectal Cancer
• Head and Neck Squamous Cell Carcinoma
• Melanoma
• Merkel Cell Carcinoma
• Mesothelioma
• Non-small Cell Lung Cancer
• Renal Cell Carcinoma

Drugs mentioned

• VET3-TGI

Snippet

Sponsor: KaliVir Immunotherapeutics | Conditions: Solid Tumor, Adult, Microsatellite Stable Colorectal Cancer | Phase 1 | Status: RECRUITING